P

Inventor

DENG SHIXIAN

US27 patents
⚠️ This page may combine multiple inventors who share the name “DENG SHIXIAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV COLUMBIA

20 patents
US11529349B2Dec 20, 2022

Aldose reductase inhibitors and uses thereof

UNIV COLUMBIA3 citations84
US10639306B2May 5, 2020

Aldose reductase inhibitors and uses thereof

UNIV COLUMBIA3 citations84
US11730737B2Aug 22, 2023

Aldose reductase inhibitors and uses thereof

UNIV COLUMBIA1 citations73
US10626113B2Apr 21, 2020

Phosphodiesterase inhibitors and uses thereof

UNIV COLUMBIA2 citations72
US7544678B2Jun 9, 2009

Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2)

UNIV COLUMBIA6 citations71
US10653648B2May 19, 2020

Histone acetyltransferase activators and compositions and uses thereof

UNIV COLUMBIA3 citations69
US11406608B2Aug 9, 2022

Histone acetyltransferase activators and compositions and uses thereof

UNIV COLUMBIA1 citations67
US11851427B2Dec 26, 2023

Phosphodiesterase inhibitors and uses thereof

UNIV COLUMBIA1 citations61
US10899756B2Jan 26, 2021

Phosphodiesterase inhibitors and uses thereof

UNIV COLUMBIA1 citations61
US8022058B2Sep 20, 2011

Agents for preventing and treating disorders involving modulation of the RyR receptors

UNIV COLUMBIA6 citations61
US7879840B2Feb 1, 2011

Agents for preventing and treating disorders involving modulation of the RyR receptors

UNIV COLUMBIA6 citations61
US11034647B2Jun 15, 2021

Histone acetyltransferase activators and uses thereof

UNIV COLUMBIA0 citations60
US7704990B2Apr 27, 2010

Agents for preventing and treating disorders involving modulation of the RyR receptors

UNIV COLUMBIA4 citations60
US12239618B2Mar 4, 2025

Histone acetyltransferase activators and compositions and uses thereof

UNIV COLUMBIA0 citations59
US11191768B2Dec 7, 2021

Histone acetyltransferase activators and uses thereof

UNIV COLUMBIA0 citations59
US12492207B2Dec 9, 2025

Compounds, pharmaceutical formulations, and methods for treatment of cancer

UNIV COLUMBIA0 citations57
US9974782B2May 22, 2018

Phosphodiesterase inhibitors and uses thereof

UNIV COLUMBIA0 citations52
US9422242B2Aug 23, 2016

Phosphodiesterase inhibitors and uses thereof

UNIV COLUMBIA0 citations52
US7718644B2May 18, 2010

Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof

UNIV COLUMBIA0 citations49
US9695193B2Jul 4, 2017

Inhibitors of Plasmodium falciparum equilibrative nucleoside transporter type I as anti-parasitic compounds

UNIV COLUMBIA1 citations41

FENG YAN

2 patents

MARKS ANDREW ROBERT

1 patent

FRANCIS YITSHAK

1 patent

DENG SHIXIAN

1 patent

SERVIER LAB

1 patent

XIE YULI

1 patent